“The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team” (2024) Voprosy onkologii, 70(3), pp. 541–549. doi:10.37469/0507-3758-2024-70-3-541-549.